J.Jill, Inc. (JILL) Reaches $8.42 After 6.00% Down Move; 13 Analysts Covering HealthEquity, Inc. (HQY)

June 14, 2018 - By Linda Melvin

HealthEquity, Inc. (NASDAQ:HQY) Logo

Among 16 analysts covering HealthEquity Inc (NASDAQ:HQY), 13 have Buy rating, 0 Sell and 3 Hold. Therefore 81% are positive. HealthEquity Inc had 50 analyst reports since August 18, 2015 according to SRatingsIntel. The company was maintained on Tuesday, March 20 by KeyBanc Capital Markets. The stock of HealthEquity, Inc. (NASDAQ:HQY) has “Outperform” rating given on Wednesday, March 23 by Barrington Research. The rating was reinitiated by JP Morgan on Friday, October 28 with “Overweight”. KeyBanc Capital Markets maintained the shares of HQY in report on Tuesday, June 5 with “Overweight” rating. As per Wednesday, June 7, the company rating was maintained by Cantor Fitzgerald. Chardan Capital Markets initiated HealthEquity, Inc. (NASDAQ:HQY) rating on Tuesday, December 13. Chardan Capital Markets has “Buy” rating and $50 target. Cantor Fitzgerald maintained the shares of HQY in report on Tuesday, September 5 with “Buy” rating. On Wednesday, March 23 the stock rating was maintained by Avondale with “Market Outperform”. The firm has “Buy” rating given on Tuesday, September 5 by KeyBanc Capital Markets. The firm has “Buy” rating by Chardan Capital Markets given on Wednesday, June 7. See HealthEquity, Inc. (NASDAQ:HQY) latest ratings:

05/06/2018 Broker: SunTrust Rating: Buy New Target: $85.0000 Maintain
05/06/2018 Broker: Robert W. Baird Old Rating: Neutral New Rating: Neutral Old Target: $61 New Target: $77 Maintain
05/06/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $72 New Target: $82 Maintain
31/05/2018 Broker: Barrington Rating: Buy New Target: $65.0000 Maintain
31/05/2018 Broker: Cantor Fitzgerald Old Rating: Overweight New Rating: Neutral Old Target: $60 Downgrade
23/05/2018 Broker: Bank of America Rating: Buy New Target: $83.0000 Initiate
24/04/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Overweight Old Target: $60 New Target: $69 Maintain
24/04/2018 Broker: J.P. Morgan Rating: Buy New Target: $69.0000 Initiate
19/04/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $65.0000 Maintain
05/04/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $66 New Target: $72 Maintain

The stock of J.Jill, Inc. (NYSE:JILL) is a huge mover today! The stock decreased 4.32% or $0.38 during the last trading session, reaching $8.42. About 254,405 shares traded. J.Jill, Inc. (NYSE:JILL) has declined 48.00% since June 14, 2017 and is downtrending. It has underperformed by 60.57% the S&P500. Some Historical JILL News: ; 15/03/2018 – J.JILL, REPORTS CEO TRANSITION; 15/03/2018 – J. JILL SEES 1Q ADJ EPS 24C, EST. 26C; 31/05/2018 – J.Jill Sees 2Q EPS 22c-EPS 24c; 15/03/2018 – Linda Heasley to Take Over CEO Role at J. Jill; 15/03/2018 – J.Jill, Inc. Announces CEO Transition; 15/03/2018 – J.Jill 4Q Adj EPS 13c; 23/03/2018 – S&PGR Rates Jill Acquisition ‘B’, Negative Outlook; 19/04/2018 – DJ JJill Inc, Inst Holders, 1Q 2018 (JILL); 31/05/2018 – J.Jill 1Q Adjusted EBITDA $31.5M; 31/05/2018 – J.Jill Ended the 1Q With $28.7M in CashThe move comes after 8 months negative chart setup for the $368.45M company. It was reported on Jun, 14 by Barchart.com. We have $7.91 PT which if reached, will make NYSE:JILL worth $22.11 million less.

HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company has market cap of $4.98 billion. The Company’s services and products include healthcare saving and spending platform, a cloud platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It has a 89.06 P/E ratio. The firm also offers online-only investment advisory services through HealthEquity Advisor, a Web tool; and healthcare incentives that enable its employer partners and health plan partners to offer, and its members to earn, financial incentives for participation in wellness programs.

More important recent HealthEquity, Inc. (NASDAQ:HQY) news were published by: Globenewswire.com which released: “HealthEquity Reports First Quarter Ended April 30, 2018 Financial Results” on June 04, 2018, also Seekingalpha.com published article titled: “HealthEquity up 3.3% post Q1 results”, Seekingalpha.com published: “HealthEquity (HQY) CEO Jon Kessler on Q1 2019 Results – Earnings Call Transcript” on June 05, 2018. More interesting news about HealthEquity, Inc. (NASDAQ:HQY) was released by: Fool.com and their article: “10 Reasons Why I’m Selling All of My Apple Stock” with publication date: June 10, 2018.

The stock increased 0.55% or $0.44 during the last trading session, reaching $80.33. About 228,188 shares traded. HealthEquity, Inc. (NASDAQ:HQY) has risen 66.90% since June 14, 2017 and is uptrending. It has outperformed by 54.33% the S&P500. Some Historical HQY News: ; 19/03/2018 – HQY SEES FY ADJ EBITDA $106.0M TO $111.0M, EST. $104.7M; 28/03/2018 – HealthEquity Appoints New Director to the Board; 06/04/2018 – HealthEquity Appoints Angelique Hill as EVP of Ops; 06/04/2018 – HealthEquity Appoints Angelique Hill as EVP of Operations; 21/04/2018 – DJ HealthEquity Inc, Inst Holders, 1Q 2018 (HQY); 15/05/2018 – HealthEquity Presenting at Conference Jun 5; 19/03/2018 – HEALTHEQUITY INC HQY.O FY2019 SHR VIEW $0.94, REV VIEW $277.8 MLN — THOMSON REUTERS l/B/E/S; 19/03/2018 – HEALTHEQUITY INC – SEES NON-GAAP NET INCOME PER DILUTED SHARE RANGE BETWEEN $0.98 TO $1.04 FOR YEAR ENDING JAN 31, 2019; 19/03/2018 – HealthEquity Sees FY19 Adj EPS 98c-Adj EPS $1.04; 19/03/2018 – HealthEquity 2Q EPS 9c

J.Jill, Inc. operates as a specialty retailer of womenÂ’s apparel under the J.Jill brand in the United States. The company has market cap of $368.45 million. It offers knit and woven tops, bottoms, and dresses, as well as sweaters and outerwear; and complementary footwear and accessories, including scarves, jewelry, and hosiery for misses, petite, and women. It has a 6.63 P/E ratio. The Company’s clients include women in 40-65 age range.

More notable recent J.Jill, Inc. (NYSE:JILL) news were published by: Seekingalpha.com which released: “Positive comp for J. Jill” on May 31, 2018, also Fool.com with their article: “Shares of J.Jill Pop 20% After Topping Analysts’ Estimates During the First Quarter” published on May 31, 2018, Seekingalpha.com published: “J. Jill Group, Inc. (JILL) CEO Linda Heasley on Q1 2018 Results – Earnings Call Transcript” on May 31, 2018. More interesting news about J.Jill, Inc. (NYSE:JILL) were released by: Seekingalpha.com and their article: “Don’t Let Go Of Hasbro – Cramer’s Lightning Round (6/5/18)” published on June 06, 2018 as well as Nasdaq.com‘s news article titled: “Mid-Afternoon Market Update: J.Jill Climbs On Earnings Beat; Scpharmaceuticals Shares Fall” with publication date: May 31, 2018.

Analysts await J.Jill, Inc. (NYSE:JILL) to report earnings on September, 4. They expect $0.23 earnings per share, down 20.69% or $0.06 from last year’s $0.29 per share. JILL’s profit will be $10.06 million for 9.15 P/E if the $0.23 EPS becomes a reality. After $0.28 actual earnings per share reported by J.Jill, Inc. for the previous quarter, Wall Street now forecasts -17.86% negative EPS growth.

Among 10 analysts covering J. Jill (NYSE:JILL), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. J. Jill had 17 analyst reports since April 3, 2017 according to SRatingsIntel. On Monday, April 3 the stock rating was initiated by Jefferies with “Buy”. The rating was maintained by Cowen & Co with “Buy” on Thursday, October 12. The company was maintained on Friday, May 26 by RBC Capital Markets. The company was downgraded on Thursday, October 12 by SunTrust. The rating was maintained by RBC Capital Markets on Thursday, July 6 with “Buy”. Deutsche Bank initiated J.Jill, Inc. (NYSE:JILL) on Monday, April 3 with “Buy” rating. The company was initiated on Monday, April 3 by Macquarie Research. RBC Capital Markets downgraded the shares of JILL in report on Thursday, October 12 to “Hold” rating. The rating was maintained by RBC Capital Markets on Tuesday, October 3 with “Buy”. RBC Capital Markets initiated it with “Outperform” rating and $16 target in Monday, April 3 report.

HealthEquity, Inc. (NASDAQ:HQY) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: